The global veterinary dermatology market is anticipated to be valued at USD 8.9 billion by 2024. The market valuation is estimated to be USD 22 billion by 2034, projected at a CAGR of 9.4%. The increasing prevalence of skin diseases in companion animals is a significant driver propelling the growth of the veterinary dermatology market. As pet ownership continues to rise globally, so does the occurrence of dermatological conditions in pets.
Environmental allergens, genetic predispositions, and lifestyle changes contribute to the growing incidence of skin issues in animals. Pet owners are becoming increasingly aware of the importance of proper dermatological care for their pets, leading to a higher demand for veterinary dermatology services and products.
One of the primary threats facing the veterinary dermatology market is the emergence of antibiotic-resistant bacteria. Antibiotic resistance poses a significant challenge in treating bacterial skin infections in animals, limiting the efficacy of conventional antibacterial drugs. This threat complicates the management of dermatological conditions in pets and underscores the need for alternative treatment approaches and the development of novel antimicrobial agents to combat resistant strains effectively.
A notable trend in the veterinary dermatology market is the growing popularity of natural and organic pet skincare products. Pet owners increasingly seek safer and eco-friendly alternatives to conventional dermatological treatments, leading to a surge in demand for natural remedies and products free from harsh chemicals and additives. This trend reflects a broader shift towards holistic pet care and wellness, emphasizing promoting skin health through natural means.
Key Takeaways from the Market Study:
- Under drug class, the antibacterial drugs are registered to expand at 9.2% CAGR by 2034.
- The United Kingdom is estimated to register at a CAGR of 10.1% by 2034.
- China experiences significant growth, projected at a CAGR of 9.8% by 2034.
- Based on route of administration, the oral segment is anticipated to expand at 9% CAGR by 2034.
“The increasing awareness among pet owners about the importance of skin health in their pets is one significant driver for the veterinary dermatology market,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!
Competitive Landscape:
A diverse range of players, including pharmaceutical companies, specialty clinics, and diagnostic laboratories, characterizes the competitive landscape of the veterinary dermatology market.
Product innovation, pricing strategies, and geographic presence drive competition. Partnerships and collaborations among industry players also play a significant role in shaping market dynamics. Some of the key developments are:
- In October 2022, Pet King Brands, Inc. expanded its ZYMOX Enzymatic Dermatology line with three new products tailored for cats and kittens, addressing ear and skin issues.
- In January 2021, Ceva Animal Health introduced Douxo S3 Pyo skincare pads for cats and dogs, enhancing the range by offering convenient antibacterial action alongside skin hydration and protection.
Key Companies Profiled:
- Elanco Animal Health Incorporated
- Vetoquinol S.A.
- Ceva
- Merck & Co., Inc.
- Zoetis, Inc.
- Virbac
- Bimeda, Inc.
- Vivaldis
- Bioiberica S.A.U
- Indian Immunologicals Ltd
Veterinary Dermatology Market – Key Segments:
By Drug Class:
- Antibacterial Drugs
- Antifungal Drugs
- Antiparasitic Drugs
- Other Drug Classes
By Indication:
- Parasitic Infections
- Allergic Infections
- Autoimmune Skin Diseases
- Skin Cancer
- Other Indications
By Route of Administration:
- Injectable
- Topical
- Oral
By Animal Type:
- Companion Animals
- Dogs
- Cats
- Horses
- Other Companion Animals
- Livestock Animals
- Bovine
- Swine
- Other Livestock Animals
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube